Microbiology

Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2

1. Erin E. Schirtzinger
2. Yunjeong Kim
3. A. Sally Davis

Reviewed by ScreenIT

A Drug Candidate for Treating Adverse Reactions Caused by Pathogenic Antibodies Inducible by SARS-CoV-2 Virus and Vaccines

1. Huiru Wang
2. Xiancong Wu
3. Lin Dai
4. Yue Hu
5. Yuekai Zhang
6. Yuxing Chen
7. Xiaoling Liu

Reviewed by ScreenIT

Niclosamide reverses SARS-CoV-2 control of lipophagy

1. Timothy J. Garrett
2. Heather Coatsworth
3. Iqbal Mahmud
4. Timothy Hamerly
5. Caroline J. Stephenson
6. Hoda S. Yazd
7. Jasmine Ayers
8. Megan R. Miller
9. John A. Lednicky
10. Rhoel R. Dinglasan

Reviewed by ScreenIT

Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model

1. Kyle L. O'Donnell
2. Amanda N. Pinski
3. Chad S. Clancy
4. Tylisha Gourdine
5. Kyle Shifflett
6. Paige Fletcher
7. Ilhem Messaoudi
8. Andrea Marzi

Reviewed by ScreenIT

A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice

1. Xavier Montagutelli
2. Matthieu Prot
3. Grégory Jouvion
4. Laurine Levillayer
5. Laurine Conquet
6. Edouard Reyes-Gomez
7. Flora Donati
8. Melanie Albert
9. Sylvie van der Werf
10. Jean Jaubert
11. Etienne Simon-Lorière

Reviewed by ScreenIT

Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection

1. Yasuo Ariumi

Reviewed by ScreenIT

Loss of N1-methylation of G37 in tRNA induces ribosome stalling and reprograms gene expression

1. Isao Masuda
2. Jae-Yeon Hwang
3. Thomas Christian
4. Sunita Maharjan
5. Fuad Mohammad
6. Howard Gamper
7. Allen R Buskirk
8. Ya-Ming Hou

• Curated by eLife

  Evaluation Summary:

  This manuscript provides evidence that loss of N1-methylation of G37 of tRNAs in bacteria on depletion of TrmD results in defects in aminoacylation and peptidyl-transfer, leading to ribosome stalling and phenotypes indicating activation of the stringent response.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

Reviewed by eLife

Therapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2

1. Dong-Kyun Ryu
2. Bobin Kang
3. Sun-Je Woo
4. Min-Ho Lee
5. Aloys SL Tijsma
6. Hanmi Noh
7. Jong-In Kim
8. Ji-Min Seo
9. Cheolmin Kim
10. Minsoo Kim
11. Eunji Yang
12. Gippeum Lim
13. Seong-Gyu Kim
14. Su-Kyeong Eo
15. Jung-ah Choi
16. Sang-Seok Oh
17. Patricia M Nuijten
18. Manki Song
19. Hyo-Young Chung
20. Carel A van Baalen
21. Ki-Sung Kwon
22. Soo-Young Lee

Reviewed by ScreenIT

A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses

1. Thomas Meunier
2. Lowiese Desmarets
3. Simon Bordage
4. Moussa Bamba
5. Kévin Hervouet
6. Yves Rouillé
7. Nathan François
8. Marion Decossas
9. Valentin Sencio
10. François Trottein
11. Fézan Honora Tra Bi
12. Olivier Lambert
13. Jean Dubuisson
14. Sandrine Belouzard
15. Sevser Sahpaz
16. Karin Séron

Reviewed by ScreenIT

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates

1. Neeltje van Doremalen
2. Robert J. Fischer
3. Jonathan E. Schulz
4. Myndi G. Holbrook
5. Brian J. Smith
6. Jamie Lovaglio
7. Benjamin Petsch
8. Vincent J. Munster

Reviewed by ScreenIT